Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Quetiapine Fumarate, and when can generic versions of Quetiapine Fumarate launch?

Quetiapine Fumarate is a drug marketed by Alkem Labs Ltd, Lupin Ltd, West-ward Pharms Int, Mylan Pharms Inc, Intellipharmaceutics, Teva Pharms, Jubilant Generics, Accord Hlthcare, Macleods Pharms Ltd, Pharmadax Inc, Apotex Inc, Actavis Grp Ptc, Torrent Pharms Ltd, Unichem Labs Ltd, Sandoz, Dr Reddys Labs Ltd, Par Pharm, Aurobindo Pharma Ltd, Alembic Pharms Ltd, and Sun Pharma Global. and is included in twenty-two NDAs.

The generic ingredient in QUETIAPINE FUMARATE is quetiapine fumarate. There are fifty-one drug master file entries for this compound. Fifty-five suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the quetiapine fumarate profile page.

Summary for Tradename: QUETIAPINE FUMARATE

Suppliers / Packagers: see list49
Bulk Api Vendors: see list107
Clinical Trials: see list349
Patent Applications: see list3,379
Formulation / Manufacturing:see details
Drug Prices:see details

Pharmacology for Tradename: QUETIAPINE FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem Labs Ltd
quetiapine fumarate
TABLET;ORAL202674-003Mar 8, 2016ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
quetiapine fumarate
TABLET;ORAL091388-003Mar 27, 2012ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
quetiapine fumarate
TABLET;ORAL203359-002May 17, 2016ABRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
quetiapine fumarate
TABLET;ORAL090749-005Mar 27, 2012ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
quetiapine fumarate
TABLET;ORAL077380-004Mar 27, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus